46 related articles for article (PubMed ID: 32880072)
21. Efficacy of Psychosocial Interventions for People with Multiple Sclerosis: A Meta-Analysis of Specific Treatment Effects.
Sesel AL; Sharpe L; Naismith SL
Psychother Psychosom; 2018; 87(2):105-111. PubMed ID: 29518781
[TBL] [Abstract][Full Text] [Related]
22. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
Hauer L; Perneczky J; Sellner J
J Neurol; 2021 Nov; 268(11):4066-4077. PubMed ID: 32719975
[TBL] [Abstract][Full Text] [Related]
23. The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study.
Dagnew B; Laslett LL; Honan CA; Blizzard L; Winzenberg T; Taylor BV; van der Mei I
Mult Scler; 2024 Jun; 30(7):877-887. PubMed ID: 38738517
[TBL] [Abstract][Full Text] [Related]
24. Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument.
Ahmad H; van der Mei I; Taylor BV; Campbell JA; Palmer AJ
Mult Scler Relat Disord; 2020 Sep; 44():102358. PubMed ID: 32650122
[TBL] [Abstract][Full Text] [Related]
25. The quality of life impact of the COVID-19 pandemic and lockdowns for people living with multiple sclerosis (MS): evidence from the Australian MS Longitudinal Study.
Henson GJ; van der Mei I; Taylor BV; Blacklow P; Claflin SB; Palmer AJ; Hurst C; Campbell JA
Qual Life Res; 2024 Jun; 33(6):1675-1689. PubMed ID: 38578380
[TBL] [Abstract][Full Text] [Related]
26. Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype.
Zhang Y; Taylor BV; Simpson S; Blizzard L; Campbell JA; Palmer AJ; van der Mei I
Mult Scler; 2021 Jul; 27(8):1262-1275. PubMed ID: 32924841
[TBL] [Abstract][Full Text] [Related]
27. Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms.
Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; van der Mei I
J Neurol; 2021 Feb; 268(2):559-568. PubMed ID: 32876720
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Berrigan LI; Fisk JD; Patten SB; Tremlett H; Wolfson C; Warren S; Fiest KM; McKay KA; Marrie RA;
Neurology; 2016 Apr; 86(15):1417-1424. PubMed ID: 26962068
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Marrie RA; Patten SB; Tremlett H; Wolfson C; Warren S; Svenson LW; Jette N; Fisk J;
Neurology; 2016 Apr; 86(14):1279-1286. PubMed ID: 26962066
[TBL] [Abstract][Full Text] [Related]
30. Confounding variables in epidemiologic studies: basics and beyond.
Kamangar F
Arch Iran Med; 2012 Aug; 15(8):508-16. PubMed ID: 22827790
[TBL] [Abstract][Full Text] [Related]
31. Cumulative impact of comorbidity on quality of life in MS.
Marrie RA; Horwitz R; Cutter G; Tyry T
Acta Neurol Scand; 2012 Mar; 125(3):180-6. PubMed ID: 21615355
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Polman CH; Reingold SC; Banwell B; Clanet M; Cohen JA; Filippi M; Fujihara K; Havrdova E; Hutchinson M; Kappos L; Lublin FD; Montalban X; O'Connor P; Sandberg-Wollheim M; Thompson AJ; Waubant E; Weinshenker B; Wolinsky JS
Ann Neurol; 2011 Feb; 69(2):292-302. PubMed ID: 21387374
[TBL] [Abstract][Full Text] [Related]
33. Comorbidities amongst patients with multiple sclerosis: a population-based controlled study.
Kang JH; Chen YH; Lin HC
Eur J Neurol; 2010 Sep; 17(9):1215-1219. PubMed ID: 20192982
[TBL] [Abstract][Full Text] [Related]
34. Comorbidity, socioeconomic status and multiple sclerosis.
Marrie R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
Mult Scler; 2008 Sep; 14(8):1091-8. PubMed ID: 18728060
[TBL] [Abstract][Full Text] [Related]
35. Burden of major musculoskeletal conditions.
Woolf AD; Pfleger B
Bull World Health Organ; 2003; 81(9):646-56. PubMed ID: 14710506
[TBL] [Abstract][Full Text] [Related]
36. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
McDonald WI; Compston A; Edan G; Goodkin D; Hartung HP; Lublin FD; McFarland HF; Paty DW; Polman CH; Reingold SC; Sandberg-Wollheim M; Sibley W; Thompson A; van den Noort S; Weinshenker BY; Wolinsky JS
Ann Neurol; 2001 Jul; 50(1):121-7. PubMed ID: 11456302
[TBL] [Abstract][Full Text] [Related]
37. Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; Ahmad H; Hussain MA; van der Mei I
J Neurol; 2021 Feb; 268(2):569-581. PubMed ID: 32880072
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
